Products

Active Pharmaceutical Ingredients

No. PRODUCT STANDARDS END USE CAS
1 CILNIDIPINE IP/JP/IH ANTI-HYPERTENSIVE 132203-70-4
2 BENIDIPINE HCl JP/IH ANTI-HYPERTENSIVE 91599-74-5
3 AZELNIDIPINE JP/IP/IH ANTI-HYPERTENSIVE 123524-52-7
4 IRON SUCROSE IH HAEMATINIC 8047-67-4
5 TORSEMIDE IP/USP DIURECTIC 56211-40-6
6 FEBANTEL IP/EP/BP ANTHELMINTIC 58306-30-2
7 TAMSULOSIN HCl IP/USP DIFFICULT URINATION 106463-17-6
8 FINASTERIDE IP/USP/EP DIFFICULT URINATION 98319-26-7
9 DUTASTERIDE IP/USP DIFFICULT URINATION 164656-23-9
10 LAFUTIDINE IH ANTI SECRETORY 118288-08-7
11 PRAZIQUANTEL IP/USP/BP ANTHELMINTIC 55268-74-1
12 CILOSTAZOL USP ANTI-HYPERTENSIVE 73963-72-1
13 LOTEPREDNOL ETABONATE IH OPHTHAMLIC STEROID 82034-46-6
14 BOSENTAN MONOHYDRATE IH ANTI HYPERTENSIVE 157212-55-0
15 PRUCALOPRIDE SUCCINATE IH INTESTINAL DISORDER 179474-85-2
16 BUPROPION HCl USP SMOKING CESSATION 31677-93-7
17 NEPAFENAC IH OPHTHALMIC NSAID 78281-72-8
18 CETILISTAT IH OBESITY 282526-98-1
19 FLUPIRTINE MALEATE IH ANALGESIC 75507-68-5
20 DIENOGEST IP/IH BIRTH CONTROL 65928-58-7
21 ULIPRISTAL ACETATE IP/IH UTERINE FIBROIDS 126784-99-4
  UNDER DEVELOPMENT      
1 VILOXAZINE HCL IH ATTENTION DEFICIENCY 35604-67-2
1 RELUGOLIX IH ENDOMETRIOSIS 737789-87-6

API Intermediates

Sr. No. Intermediates CAS END USE
1 2-Cyanoacetic acid-1-(diphenylmethyl)-3-azetidinyl ester 116574-14-2 Azelnidipine
2 Isopropyl-2-(3-nitrobenzylidene)acetoacetate 39562-25-9
3 3-Amino-3-iminopropanoic acid-1-(diphenylmethyl)-3-azetidinyl ester acetate 170749-59-4
4 1-Benzyl piperidin-3-ol 14813-01-5 Benidipine
5 2,6-dimethyl-5-methoxycarbonyl-4-(3-nitrophenyl)- 1,4-dihydropyridine-3-carboxylic acid 74936-72-4
6 2-methoxyethyl-2-(3-nitrobenzyledene) Acetoacetate 39562-22-6 Cilnidipine
7 3-Amino crotonic acid cinnamyl ester 103909-86-0
8 2-methoxy-N-[2-nitro-5-(phenylthio)phenyl] Acetamide 63470-85-9 Febantel
9 6-Hydroxy-3,4-dihydro-2(1H)-quinolinone 54197-66-9 Cilostazol
Products protected by valid patents are not offered for sale in countries where the sale of such products constitute a patent infringement.